Drugmaker Biogen is pulling the plug on its controversial Alzheimer's drug Aduhelm, following disappointing sales. It had been expected to be a blockbuster product. A drugmaker is pulling the plug on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback